【24h】

THE HIDDEN PHARMACOLOGY OF THE HUMAN GPCR-OME

机译:人类GPCR-OME的隐藏药理学

获取原文

摘要

My view of the present state of research on GPCR drug discovery With nearly 900 members, the human GPCR-ome comprises the largest family of druggable targets in the genome although most members have not been chemically interrogated. G protein-coupled receptors(GPCRs)constitute the single largest class of druggable targets in the human genome [1]. The human genome includes genes for~900 olfactory and non-olfactory GPCRs and careful analyses estimate the number of non-olfactory GPCRs to be between 342 and 356(http://www.iuphardb.org/index.jsp)[2]. Of these, approximately 38% are classified as "orphans", i.e.,their natural(endogenous)ligands remain unknown(see IUPHAR GPCR Database at: http://www.iuphar-db.org/index.jsp). Additionally a significant proportion of the non-orphan GPCRs remain incompletely or inaccurately characterized with respect to the ligands that modulate their activity.
机译:我对目前关于GPCR药物发现的研究状态,具有近900名成员,人类GPCR-OME包括基因组中最大的可毒靶系列,尽管大多数成员没有化学询问。 G蛋白偶联受体(GPCR)构成人类基因组中的单一最大类别的可用靶标[1]。人类基因组包括〜900嗅机和非嗅觉GPCR的基因,仔细分析估计非嗅觉GPCR的数量在342到356之间(http://www.iphardb.org/index.jsp)[2]。其中,大约38%被归类为“孤儿”,即,它们的天然(内源性)配体仍然未知(请参阅iuphar GPCR数据库:http://www.iuphar-db.org/index.jsp)。另外,非孤儿GPCR的显着比例不完全或不准确地表征,相对于调节其活性的配体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号